Alterations in vascular reactivity in single- and double-transgenic mice coexpressing human APP-C100 and mutant SOD1 genes

Chinese Medical Journal

Volumn 115, Issue 5, 2002, Pages 696-701

  Xue, Shouru ^a   Li, Qiaoxin ^b   Khalil, Zeinab ^b  

^a SOOCHOW UNIVERSITY   (China)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

amyloid; Alzheimer's disease; Blood flow; Cu Zn superoxide dismutase; Microvasculature; Transgenic mice

Indexed keywords

ACETYLCHOLINE; AMYLOID BETA PROTEIN; NITROPRUSSIDE SODIUM; PROTEIN PRECURSOR; SUPEROXIDE DISMUTASE; VASODILATOR AGENT;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD FLOW VELOCITY; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; ENDOTHELIUM LESION; FOOT PAD; GENE MUTATION; HUMAN; MICROVASCULATURE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN TRANSPORT; STATISTICAL ANALYSIS; TRANSGENIC MOUSE; VASCULAR ENDOTHELIUM; VASODILATATION;

ACETYLCHOLINE; AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BLOOD FLOW VELOCITY; HINDLIMB; HUMANS; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; MICE, TRANSGENIC; MUTATION; NITROPRUSSIDE; PEPTIDE FRAGMENTS; SUPEROXIDE DISMUTASE; VASODILATOR AGENTS;

EID: 0036263283     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Cerebrovascular pathology in Alzheimer's disease: Cause, effect or epiphenomenon?
2. Cerebrovascular degeneration is related to amyloid-β protein deposition in Alzheimer's disease
3. Production of the Alzheimer amyloid-β protein by normal proteolytic processing
4. Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids
5. The amyloid precursor protein of Alzheimer disease in human brain and blood
6. Endothelial cell dysfunction in response to intracellular overexpression of amyloid precursor protein
7. Secreted amyloid β-protein similar to that in the senile plaques of AD is increased in vivo by the Presenilin 1 and 2 and APP mutations linked to familial AD
8. β-amyloid-mediated vasoactivity and vascular endothelial damage
9. Cerebrovascular endothelial dysfunction mediated by beta-amyloid
10. Characteristics of the in vitro vasoactivity of beta-amyloid peptides
11. Mechanisms underlying the vascular activity of beta-amyloid protein fragment (beta A(4) 25-35) at the level of skin microvasculature
12. Increased susceptibility to ischemic brain damage in transgenic mice overexpressing the amyloid precursor protein
13. SOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein
14. Intracellular accumulation of detergent-soluble amyloidogenic Aβ fragment of Alzheimer's disease precursor protein in the hippocampus of aged transgenic mice
15. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation
16. Secretion of Alzheimer's disease Aβ amyloid peptide by activated human platelets
17. High levels of circulating β-amyloid peptides do not cause cerebral amyloidosis in transgenic mice
18. Involvement of endothelial and non-endothelial mechanisms in the vasoconstrictor activity of Aβ peptide
19. Alzheimer's β-amyloid vasoactivity: Identification of a novel β-amyloid conformational intermediate
20. Age-dependent neuronal and synaptic degeneration in mice transgenic for the C terminus of the amyloid precursor protein
21. 1-42 are potent central nervous system neurotoxins
22. Glial expression of the beta-amyloid precursor protein (APP) in global ischemia
23. Mutant presenilins of AD increase production of 42-residue amyloid β-protein in both transfected cells and transgenic mice